A quantum biochemistry approach to investigate checkpoint inhibitor drugs for cancer-Reference-Cited by-同舟云学术

A quantum biochemistry approach to investigate checkpoint inhibitor drugs for cancer

Author:

Tavares Ana Beatriz M. L. A.¹²³⁴,Lima Neto José X.⁵⁶⁷⁴^ORCID,Fulco Umberto L.⁵⁶⁷⁴^ORCID,Albuquerque Eudenilson L.⁵⁶⁷⁴^ORCID

Affiliation:

1. Hospital das Clínicas

2. Universidade Federal de Pernambuco

3. Recife

4. Brazil

5. Departamento de Biofísica e Farmacologia

6. Universidade Federal do Rio Grande do Norte

7. Natal

Abstract

We investigate the coupling profiles of the receptor PD-1 in complex with its natural ligand PDL1 and two inhibitor drugs.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

Reference38 articles.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Immune-oncological drug atezolizumab;Quantum Chemistry Methods for Oncological Drugs;2024

3. Immune-oncological drug pembrolizumab;Quantum Chemistry Methods for Oncological Drugs;2024

4. Immune-oncological drug nivolumab;Quantum Chemistry Methods for Oncological Drugs;2024

5. Optoelectronics properties;Quantum Chemistry Methods for Oncological Drugs;2024